Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 17 Jun 2021

Prognostic Significance of Regional/Systemic Metabolic Parameters on 18F-FDG PET in Pulmonary Lymphoepithelioma-Like Carcinoma

in Thoracic Oncology

Yongjiang Li
Wenbiao Zhang
Hu Zhang
Junfeng Hu
Chao Zhou
Xu Zhang
Wei Fan

Frontiers in Oncology

doi 10.3389/fonc.2021.675961

2,813 views
2 citations

Original Research

Published on 17 Jun 2021

Real Life Data on Patient-Reported Outcomes and Neuro-Cognitive Functioning of Lung Cancer Patients: The PRO-Long Study

in Thoracic Oncology

Lotte Van Der Weijst
Veerle Surmont
Wim Schrauwen
Yolande Lievens

Frontiers in Oncology

doi 10.3389/fonc.2021.685605

4,089 views
8 citations

Original Research

Published on 17 Jun 2021

Integrated Analysis of Genomic and Immunological Features in Lung Adenocarcinoma With Micropapillary Component

in Thoracic Oncology

Shirong Zhang
Yang Xu
Pan Zhao
Hua Bao
Xiyong Wang
Rui Liu
Rujun Xu
Jingjing Xiang
Hong Jiang
Junrong Yan

Frontiers in Oncology

doi 10.3389/fonc.2021.652193

6,758 views
23 citations

Original Research

Published on 16 Jun 2021

Hypofractionated Volumetric-Modulated Arc Radiotherapy for Patients With Non-Small-Cell Lung Cancer Not Suitable for Surgery or Conventional Chemoradiotherapy or SBRT

in Thoracic Oncology

Junyue Shen
Dan Yang
Mailin Chen
Leilei Jiang
Xin Dong
Dongming Li
Rong Yu
Huiming Yu
Anhui Shi

Frontiers in Oncology

doi 10.3389/fonc.2021.644852

8,813 views
10 citations

Original Research

Published on 16 Jun 2021

Co-Occurring Potentially Actionable Oncogenic Drivers in Non-Small Cell Lung Cancer

in Thoracic Oncology

Yiming Zhao
Shuyuan Wang
Zhengyu Yang
Yu Dong
Yanan Wang
Lele Zhang
Hai Hu
Baohui Han

Frontiers in Oncology

doi 10.3389/fonc.2021.665484

9,447 views
18 citations

Original Research

Published on 16 Jun 2021

The Angiotensin-Converting Enzyme Inhibitory State Promotes the Transformation of Non-Small Cell Lung Cancer Blood Supply Pattern Toward Vasculogenic Mimicry Formation

in Thoracic Oncology

Kandi Xu
Huize Han
Yexin Luo
Hong Ye
Hongxia Lin
Lei Ni

Frontiers in Oncology

doi 10.3389/fonc.2021.663671

4,289 views
11 citations

Original Research

Published on 15 Jun 2021

An EBC/Plasma miRNA Signature Discriminates Lung Adenocarcinomas From Pleural Mesothelioma and Healthy Controls

in Thoracic Oncology

Alice Faversani
Chiara Favero
Laura Dioni
Angela Cecilia Pesatori
Valentina Bollati
Matteo Montoli
Valeria Musso
Andrea Terrasi
Nicola Fusco
Mario Nosotti

Frontiers in Oncology

doi 10.3389/fonc.2021.643280

5,956 views
18 citations

Original Research

Published on 14 Jun 2021

Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma

in Thoracic Oncology

Xuanzong Li
Shujun Zhai
Jianbo Zhang
Dai Zhang
Shijiang Wang
Linlin Wang
Jinming Yu

Frontiers in Oncology

doi 10.3389/fonc.2021.698465

7,094 views
19 citations

Original Research

Published on 14 Jun 2021

EGFR-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes

in Thoracic Oncology

Rui Jin
Ling Peng
Jiawei Shou
Jin Wang
Yin Jin
Fei Liang
Jing Zhao
Mengmeng Wu
Qin Li
Bin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.680804

21,124 views
50 citations

Mini Review

Published on 11 Jun 2021

Treatment of Advanced-Stage Large Cell Neuroendocrine Cancer (LCNEC) of the Lung: A Tale of Two Diseases

in Thoracic Oncology

Tahani Atieh
Chao H. Huang

Frontiers in Oncology

doi 10.3389/fonc.2021.667468

11,579 views
16 citations

Original Research

Published on 10 Jun 2021

Low Expression of ADCY4 Predicts Worse Survival of Lung Squamous Cell Carcinoma Based on Integrated Analysis and Immunohistochemical Verification

in Thoracic Oncology

Zhicong Liu
Lixin Ru
Zhenchao Ma

Frontiers in Oncology

doi 10.3389/fonc.2021.637733

4,642 views
7 citations

Original Research

Published on 07 Jun 2021

Identification of High-Risk of Recurrence in Clinical Stage I Non-Small Cell Lung Cancer

in Thoracic Oncology

Yasuhiro Tsutani
Yoshihisa Shimada
Hiroyuki Ito
Yoshihiro Miyata
Norihiko Ikeda
Haruhiko Nakayama
Morihito Okada

Frontiers in Oncology

doi 10.3389/fonc.2021.622742

4,054 views
6 citations

Correction

Published on 02 Jun 2021

Corrigendum: Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors

in Thoracic Oncology

Tao Hou
Shun Jiang
Yapeng Wang
Yangchun Xie
Haixia Zhang
Yeqian Feng
Fang Ma
Jin’an Ma
Xianling Liu
Chunhong Hu

Frontiers in Oncology

doi 10.3389/fonc.2021.705406

2,283 views

Original Research

Published on 02 Jun 2021

Comparison of Clinical Efficacy of Alectinib Versus Crizotinib in ALK-Positive Non-Small Cell Lung Cancer: A Meta-Analysis

in Thoracic Oncology

Hao Tang
Longyu Jin
Zhang Zhang
Zhibin Jiang
Zeeshan Malik

Frontiers in Oncology

doi 10.3389/fonc.2021.646526

8,693 views
10 citations

Mini Review

Published on 01 Jun 2021

Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer

in Thoracic Oncology

Daniel R. Principe
Lauren Chiec
Nisha A. Mohindra
Hidayatullah G. Munshi

Frontiers in Oncology

doi 10.3389/fonc.2021.684098

13,296 views
78 citations

Original Research

Published on 31 May 2021

Survival Analysis and Prediction Model for Pulmonary Sarcomatoid Carcinoma Based on SEER Database

in Thoracic Oncology

Mingjing Chen
Qiao Yang
Zihan Xu
Bangyu Luo
Feng Li
Yongxin Yu
Jianguo Sun

Frontiers in Oncology

doi 10.3389/fonc.2021.630885

6,169 views
29 citations

Original Research

Published on 31 May 2021

A Retrospective Study on Using a Novel Single Needle Cone Puncture Approach for the Iodine-125 Seed Brachytherapy in Treating Patients With Thoracic Malignancy

in Thoracic Oncology

Fenge Li
Liping Wang
Yixiang Zhang
Weihong Feng
Tao Ju
Zaiping Liu
Zhenglu Wang
Xueming Du

Frontiers in Oncology

doi 10.3389/fonc.2021.640131

3,968 views
11 citations

Systematic Review

Published on 31 May 2021

Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma

in Thoracic Oncology

Hoda Saghaeiannejad Esfahani
Cory M. Vela
Aman Chauhan

Frontiers in Oncology

doi 10.3389/fonc.2021.653153

7,674 views
20 citations

Review

Published on 28 May 2021

Angiogenesis Inhibitors in Small Cell Lung Cancer

in Thoracic Oncology

Agnese Montanino
Anna Manzo
Guido Carillio
Giuliano Palumbo
Giovanna Esposito
Vincenzo Sforza
Raffaele Costanzo
Claudia Sandomenico
Gerardo Botti
Maria C. Piccirillo

Frontiers in Oncology

doi 10.3389/fonc.2021.655316

12,121 views
62 citations

Original Research

Published on 27 May 2021

Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades

in Thoracic Oncology

Xiaoyan Wang
Bingchen Wu
Zhengqing Yan
Guoqiang Wang
Shiqing Chen
Jian Zeng
Feng Tao
Bichun Xu
Honggang Ke
Mei Li

Frontiers in Oncology

doi 10.3389/fonc.2021.650122

6,907 views
26 citations

Original Research

Published on 27 May 2021

Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study

in Thoracic Oncology

Saeka Egami
Hitoshi Kawazoe
Hironobu Hashimoto
Ryuji Uozumi
Toko Arami
Naomi Sakiyama
Yuichiro Ohe
Hideo Nakada
Tohru Aomori
Shinnosuke Ikemura

Frontiers in Oncology

doi 10.3389/fonc.2021.618570

7,671 views
26 citations

Review

Published on 25 May 2021

Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies

in Thoracic Oncology

Kenneth K. W. To
Winnie Fong
William C. S. Cho

Frontiers in Oncology

doi 10.3389/fonc.2021.635007

50,257 views
142 citations

Systematic Review

Published on 24 May 2021

Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer

in Thoracic Oncology

Xiaoshun Shi
Xiaoying Dong
Jianxue Zhai
Xiguang Liu
Di Lu
Zhen Ni
Hua Wu
Kaican Cai

Frontiers in Oncology

doi 10.3389/fonc.2021.608608

4,492 views
7 citations

Original Research

Published on 24 May 2021

Molecular Identification and Genetic Characterization of Early-Stage Multiple Primary Lung Cancer by Large-Panel Next-Generation Sequencing Analysis

in Thoracic Oncology

Guotian Pei
Mingwei Li
Xianjun Min
Qiang Liu
Dasheng Li
Yingshun Yang
Shuai Wang
Xiaoyu Wang
Huina Wang
Huanqing Cheng

Frontiers in Oncology

doi 10.3389/fonc.2021.653988

9,162 views
29 citations

1,971 articles

articles

Prognostic Significance of Regional/Systemic Metabolic Parameters on 18F-FDG PET in Pulmonary Lymphoepithelioma-Like Carcinoma

Real Life Data on Patient-Reported Outcomes and Neuro-Cognitive Functioning of Lung Cancer Patients: The PRO-Long Study

Integrated Analysis of Genomic and Immunological Features in Lung Adenocarcinoma With Micropapillary Component

Hypofractionated Volumetric-Modulated Arc Radiotherapy for Patients With Non-Small-Cell Lung Cancer Not Suitable for Surgery or Conventional Chemoradiotherapy or SBRT

Co-Occurring Potentially Actionable Oncogenic Drivers in Non-Small Cell Lung Cancer

The Angiotensin-Converting Enzyme Inhibitory State Promotes the Transformation of Non-Small Cell Lung Cancer Blood Supply Pattern Toward Vasculogenic Mimicry Formation

An EBC/Plasma miRNA Signature Discriminates Lung Adenocarcinomas From Pleural Mesothelioma and Healthy Controls

Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma

EGFR-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes

Treatment of Advanced-Stage Large Cell Neuroendocrine Cancer (LCNEC) of the Lung: A Tale of Two Diseases

Low Expression of ADCY4 Predicts Worse Survival of Lung Squamous Cell Carcinoma Based on Integrated Analysis and Immunohistochemical Verification

Identification of High-Risk of Recurrence in Clinical Stage I Non-Small Cell Lung Cancer

Corrigendum: Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors

Comparison of Clinical Efficacy of Alectinib Versus Crizotinib in ALK-Positive Non-Small Cell Lung Cancer: A Meta-Analysis

Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer

Survival Analysis and Prediction Model for Pulmonary Sarcomatoid Carcinoma Based on SEER Database

A Retrospective Study on Using a Novel Single Needle Cone Puncture Approach for the Iodine-125 Seed Brachytherapy in Treating Patients With Thoracic Malignancy

Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma

Angiogenesis Inhibitors in Small Cell Lung Cancer

Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades

Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study

Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies

Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer

Molecular Identification and Genetic Characterization of Early-Stage Multiple Primary Lung Cancer by Large-Panel Next-Generation Sequencing Analysis